Ablation of Myocardial Tissue With Nanosecond Pulsed Electric Fields by Xie, Fei et al.
Old Dominion University
ODU Digital Commons
Bioelectrics Publications Frank Reidy Research Center for Bioelectrics
2015
Ablation of Myocardial Tissue With Nanosecond
Pulsed Electric Fields
Fei Xie




Old Dominion University, apakhomo@odu.edu
Iurii Semenov
Old Dominion University, isemenov@odu.edu
Shu Xiao
Old Dominion University, sxiao@odu.edu
See next page for additional authors
Follow this and additional works at: https://digitalcommons.odu.edu/bioelectrics_pubs
Part of the Biomedical Commons, Biomedical Engineering and Bioengineering Commons,
Cardiology Commons, and the Nanoscience and Nanotechnology Commons
This Article is brought to you for free and open access by the Frank Reidy Research Center for Bioelectrics at ODU Digital Commons. It has been
accepted for inclusion in Bioelectrics Publications by an authorized administrator of ODU Digital Commons. For more information, please contact
digitalcommons@odu.edu.
Repository Citation
Xie, Fei; Varghese, Frency; Pakhomov, Andrei G.; Semenov, Iurii; Xiao, Shu; Philpott, Jonathan; and Zemlin, Christian, "Ablation of
Myocardial Tissue With Nanosecond Pulsed Electric Fields" (2015). Bioelectrics Publications. 61.
https://digitalcommons.odu.edu/bioelectrics_pubs/61
Original Publication Citation
Xie, F., Varghese, F., Pakhomov, A.G., Semenov, I., Xiao, S., Philpott, J., & Zemlin, C. (2015). Ablation of myocardial tissue with
nanosecond pulsed electric fields. PLoS ONE, 10(12), e0144833. doi: 10.1371/journal.pone.0144833
Authors
Fei Xie, Frency Varghese, Andrei G. Pakhomov, Iurii Semenov, Shu Xiao, Jonathan Philpott, and Christian
Zemlin
This article is available at ODU Digital Commons: https://digitalcommons.odu.edu/bioelectrics_pubs/61
RESEARCH ARTICLE
Ablation of Myocardial Tissue With
Nanosecond Pulsed Electric Fields
Fei Xie1,2, Frency Varghese1,2, Andrei G. Pakhomov2, Iurii Semenov2, Shu Xiao2,
Jonathan Philpott3, Christian Zemlin1,2*
1 Department of Electrical and Computer Engineering, Old Dominion University, Norfolk, Virginia, United
States of America, 2 Center for Bioelectrics, Old Dominion University, Norfolk, Virginia, United States of





Ablation of cardiac tissue is an essential tool for the treatment of arrhythmias, particularly of
atrial fibrillation, atrial flutter, and ventricular tachycardia. Current ablation technologies suf-
fer from substantial recurrence rates, thermal side effects, and long procedure times. We
demonstrate that ablation with nanosecond pulsed electric fields (nsPEFs) can potentially
overcome these limitations.
Methods
We used optical mapping to monitor electrical activity in Langendorff-perfused New Zealand
rabbit hearts (n = 12). We repeatedly inserted two shock electrodes, spaced 2–4 mm apart,
into the ventricles (through the entire wall) and applied nanosecond pulsed electric fields
(nsPEF) (5–20 kV/cm, 350 ns duration, at varying pulse numbers and frequencies) to create
linear lesions of 12–18 mm length. Hearts were stained either with tetrazolium chloride
(TTC) or propidium iodide (PI) to determine the extent of ablation. Some stained lesions
were sectioned to obtain the three-dimensional geometry of the ablated volume.
Results
In all animals (12/12), we were able to create nonconducting lesions with less than 2 sec-
onds of nsPEF application per site and minimal heating (< 0.2°C) of the tissue. The geome-
try of the ablated volume was smoother and more uniform throughout the wall than typical
for RF ablation. The width of the lesions could be controlled up to 6 mm via the electrode
spacing and the shock parameters.
Conclusions
Ablation with nsPEFs is a promising alternative to radiofrequency (RF) ablation of AF. It
may dramatically reduce procedure times and produce more consistent lesion thickness
than RF ablation.
PLOS ONE | DOI:10.1371/journal.pone.0144833 December 14, 2015 1 / 15
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Introduction
Ablation of myocardial tissue is an essential technique for the treatment of cardiac arrhythmias
[1,2]. It can be used to directly ablate arrhythmogenic tissue or atrial locations that exhibit
complex fractionated atrial electrograms [3]. Ablation can also be used to create nonconduct-
ing lesions, which can be placed around arrhythmogenic tissue to contain the arrhythmic activ-
ity, or between anatomical landmarks to interrupt reentrant pathways [4]. The most common
use for cardiac ablation is in the treatment of atrial fibrillation (AF) and flutter, but it is also
important in the ablation of ventricular tachycardia [5].
Myocardial tissue is most commonly ablated by application of radiofrequency currents via
monopolar endocardial catheters. The RF currents lead to resistive heating, especially in the
vicinity of the catheter electrode, and eventually to necrosis of tissue around the catheter due to
hyperthermia. The duration of RF application is calibrated to obtain ablation all the way
through the cardiac wall. By placing individual RF ablations side by side, non-conducting
lesions are created. RF ablation achieves excellent acute success rates, e.g. the acute isolation of
the pulmonary veins is almost always achieved [6].
The most important limitation of RF ablation is its high recurrence rate, especially for non-
paroxysmal AF [7,8]. AF recurs within months to years after the ablation, and recurrence is
commonly attributed to gaps in the lesions [9]. Control over the lesion depth and geometry is
limited, because RF energy is applied from the endocardial surface, so the lesion profile is
inherently variable from endo- to epicardium, and even irrigated catheter tips cannot
completely solve this problem [10]. Furthermore, blood vessels act as a heterogeneous cooling
network during RF ablations and further limit the consistency that is achievable [11].
RF ablation has a significant complication rate (approximately 4%), and complications
include stroke, tamponade, vascular injury, pulmonary vein occlusion, and atrioesophageal fis-
tulae [12–14]. Many of the complications may be related to the generation of heat during RF
application. Also, RF procedures are lengthy, on the order of 2–3.5 hours [15,16], which poses
a general surgical risk and ties up hospital resources thus limiting patient throughput and EP
lab efficiency.
A more recent alternative to RF ablation is cryoablation. Cryoablation is faster [17], and
thermal complications associated with RF may occur at lower rates [18], while the effectiveness
is comparable to that of RF ablation [19].
Here, we demonstrate an alternative physical ablation mechanism that is based on applying
very short (nanosecond) pulsed electric fields (nsPEFs) and may overcome the limitations of
RF- and cryoablation. Ablation with nsPEFs kills the targeted cells by porating their mem-
brane, allowing calcium and other components of the extracellular medium to enter the cell. It
is non-thermal, fast, and gives better control over the lesion geometry than thermal ablation.
Ablation with nsPEFs has been successfully used for tumors [20], but not yet for cardiac tissue.
The use of nanosecond pulses is motivated by their distinct mechanism of interaction with
the cell membrane potential, with is markedly different from that of longer (millisecond or
above) pulses. In conventional stimulation, membranes act as barriers for the movement of
free electrolyte charges in the externally applied electric field. The capacitive charging of mem-
branes amplifies the external field by a factor of several thousands (known as the membrane
amplification factor) [21–23]. This amplification enables the electroporation of cells by exter-
nal fields which are many orders of magnitude weaker than the local transmembrane field
required for electroporation. In a syncytial tissue, the electrical connections between cells
restrict the amplification; hence it is predominantly the areas at the cathode and at virtual cath-
odes formed by electrical inhomogeneities that experience electroporation when the E-field is
turned on [24].
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In contrast, nsPEF stimuli are too brief for capacitive charging, and displacement currents
dominate over conduction currents [21,25]. Therefore intercellular electric connections do not
affect (or just minimally affect) membrane charging, and every cell even in the syncytial tissue
behaves as an independent entity. This situation is electrically equivalent to each cell having its
own virtual cathode, and electroporation is not affected by the vicinity to the cathode. Instead,
all cells within a high enough electric field area. For the same reason (not relying on conduction
currents), nsPEF penetrates deeper and the E-field distribution in tissue is less affected by elec-
trical inhomogeneities [21,25,26], resulting in more uniform ablation.
In this study, nsPEFs are applied via two thin parallel wire electrodes that penetrate the
myocardial wall and ablate the volume between the electrodes. Lesions are created by repeated
application (as in the case of RF ablation).
Methods
Surgical preparation
The IACUC of Old Dominion University reviewed and approved our animal protocol for the
experiments on which we report (protocol number 13–017). New Zealand white rabbits of
either sex (3–4 kg, n = 12) were heparinized (500 IU/kg) and brought to a surgical plane of
anesthesia with 2.5–4% isoflurane. The heart was rapidly removed, the aorta cannulated and
flushed with ice cold Tyrode solution (in mM: NaCl: 128.2, NaCO3: 20, NaH2PO4: 1.2, MgCl2:
1.1, KCl: 4.7, CaCl2: 1.3, glucose: 11.1), and the heart was placed in a Langendorff-perfusion
setup, where it was perfused and superfused with warm oxygenated Tyrode solution (37
±0.5°C) at a constant pressure of 60–80 mmHg. After 30 min equilibration, 10–15 mM of 2,
3-butanedione monoxime was added to eliminate contractions.
Optical mapping
The preparation was stained with the near-infrared dye DI-4-ANBDQBS. A stock solution was
made by dissolving 10 mg dye in 1.2 ml of pure ethanol; for each experiment, 30 μL of the
stock solution was diluted with 15 mL of Tyrode's solution and injected as a bolus. A 1000
mW, 671 nm diode laser (Shanghai Dream Lasers) was directed through a 5 degree conical dif-
fusor and then through a dichroic mirror (λcrit = 690 nm) onto the heart to achieve uniform
illumination. Fluorescence light passed the dichroic mirror and a 715 nm long pass filter and
was recorded with a CCD camera (“Little Joe”, SciMeasure, Decatur, GA) at 1000 frames per
second.
Ablation electrodes and choice of ablation sites
Ablation electrodes were made of two parallel 250 μm tungsten needles (see Fig 1A). The elec-
trode spacing was adjustable from 2 to 6 mm, and the electrodes were uninsulated over the ter-
minal 4 mm and sharpened at the tip. Electrodes were dipped into surgical ink to mark the
insertion sites and then inserted into the right or left epicardium (see Fig 1B), so that they pene-
trated the entire ventricular wall. Ablation sites were chosen at least 1 cm away from the sep-
tum. When linear lesions were desired, 4–5 consecutive ablations were performed next to each
other to create a linear lesion of 12–18 mm length.
Pulse generation
Nanosecond pulses were created with a transmission line generator (see Fig 2A). A double
shielded coaxial cable (RG-217U) was used as a capacitor (C = 3.1 nF). An additional resistor
Zm = 13.7O was placed in parallel with the heart to achieve impedance matching between the
Ablation with Nanosecond Pulsed Electric Fields
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transmission line and the load. In theory, this setup should charge the transmission line until
the breakdown voltage of the spark gap is reached and apply rectangular pulses of duration
t = 2l/v to the load, where l is the length of the transmission line and v the speed of light in the
transmission line. In our case, l = 35 m, v = 0.66 c (c is the speed of light), and consequently,
t350 ns [27] (see Fig 2B). The actual pulse shape was recorded with an oscilloscope (Tektro-
nix 1001B, Beaverton, OR) and followed the theoretical prediction with good accuracy (see
Fig 2C).
Ablation protocol
At each ablation site, we applied trains of 350 ns pulses (either 6 pulses at 3 Hz of 20 pulses at 1
Hz) of different amplitudes. We used an adjustable spark gap to allow the adjustment of the
pulse amplitude, the pulse frequency was adjusted by adjusting the supply voltage, provided by
a 0–20 kV power supply (EH Series, Glassman, Highbridge, NJ). When we generated trains of
Fig 1. Electrode configuration for nsPEF ablation. A: Electrode geometry: Two parallel 250 μm tungsten needles uninsulated at the tip (yellow segment).
B: Electrode placement in the tissue. A slab of cardiac tissue (pink) is penetrated by two needle electrodes. Upon shock delivery, an area between and
around the electrodes is ablated (yellow).C: Electrode placement in a rabbit heart. Electrodes were inserted from the epicardium, penetrating all the way
through the myocardial wall.
doi:10.1371/journal.pone.0144833.g001
Fig 2. Electric pulse generation and shape. A: Pulse generation with a transmission line generator. Rcharge is the charging resistor, Ztl is the impedance of
the transmission line, Ztissue is the impedance of the tissue, and Zm is the additional impedance added in parallel to the tissue in order to match the impedance
of the load to that of the transmission line. VBD is the breakdown voltage of the spark gap, adjustable by changing its width and L is the length of the
transmission line.B: Theoretical pulse shape, for the diagram in Panel A, where v is the speed of light in the transmission line. Pulse duration is proportional
to the length of the transmission line in Panel A. C: Experimentally measured pulse shape.
doi:10.1371/journal.pone.0144833.g002
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pulses, the pulse amplitude was reproducible within ± 0.2 kV over the amplitude range used in
this study.
Lesion analysis
For each element of the lesion, the two surface insertion points A and B of the electrodes were
identified. At the midpoint of the line AB, the extension of the lesion perpendicular to the line
AB was considered the width of the lesion segment. The width of the lesion was defined as the
average of the widths of the segments.
PI/TTC staining and sectioning
After the creation and electrophysiological evaluation, preparations were stained either with
propidium iodide (PI, 30 mM/30 min) or tetrazolium chloride (TTC, 30 mM/20 min), for fur-
ther study of the geometry of the ablated volume. For PI stains, we subsequently washed out
the PI using our coronary perfusion for 40 minutes, leaving only the cells with compromised
membrane stained with PI [28].
For both TTC and PI stains we cut lesions out of the tissue preparation and mounted each
lesion separately in a block of agar. We then sectioned the lesions (section thickness: 300 μm).
For PI stains, we recorded the fluorescence (illuminated at λ = 532 nm) for each section. By
defining a fluorescence threshold that corresponds to dead tissue, the ablated area was
identified.
Modeling of field distribution
We used the COMSOL Multiphysics package (COMSOL, Palo Alto, California) for finite ele-
ment modeling of field distributions. We modeled the tissue as a circular, homogeneous sheet
with uniform conductance and a radius of 4 cm. At the electrode locations, the sheet had two
circular holes of 250 μm diameter (the electrode diameter), spaced 2 mm apart. The Laplace
equation, ΔV = 0, was solved on the tissue domain for the transmembrane voltage. The bound-
ary conditions were that at the interior (electrode) holes, V equaled the respective applied elec-
trode potentials, and at the outer boundary, V was zero.
Results
Single nsPEF ablations create conduction block
Ablation with nsPEFs consistently created conduction block if the field strength was sufficient.
Fig 3 shows a representative example of conduction block creation, recorded with optical map-
ping. Panel A shows a photograph of the cardiac surface, including the stimulation electrode.
Panel B shows the same cardiac surface after nsPEF application, with two spots of surgical ink
indicating the positions of the ablation electrodes. Panels C and D compare the action potential
amplitudes (obtained via optical mapping) before and after nsPEF application, showing that
the action potential amplitude goes to zero in the region surrounding the nsPEF electrodes.
Panels E and F illustrate the propagation of excitation before and after nsPEF application.
Before the application, excitation propagates in all directions, with elliptical isochrones whose
long axis corresponds to the local fiber direction. After the shock, propagation in the direction
of the nsPEF application is blocked, so that excitation propagates around this electrically inac-
tive region, as shown by the smoothly changing activation times along this path, to eventually
excite the tissue on the other side of the nsPEF ablation. Note that the data in Panel F do not
exclude the possibility that the observed block is really just very slow conduction (which would
excite the tissue on the other side of the lesion after the wave that went around the lesion
Ablation with Nanosecond Pulsed Electric Fields
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arrived). This interpretation appears, however, contrived in light of the absence of electrical
activity in the treated region (Panel D) and the evidence of cell death in this region presented
below.
The field necessary for ablation depends on the shock parameters and electrode spacing (see
Fig 4). For our default parameters (2.3 mm spacing, 6 shocks at 3 Hz), field strengths above 2.3
kV consistently caused block (n = 19). When we changed to 20 shocks at 1 Hz, a lower pulse
amplitude of 2.0 kV was consistently sufficient (n = 5). For an electrode separation of 4 mm
(20 pulses at 1 Hz), a pulse amplitude of 4 kV was consistently sufficient (n = 3).
In general, we found that pulse amplitudes above half the thresholds mentioned above were
still sometimes successful in creating block (2/5), while shock amplitudes below 50% of the
Fig 3. Propagation of excitation before and after nsPEF application. A: Photograph of the cardiac
surface before ablation. The stimulation electrode (marked “SE”) is used to initiate electrical activation.B:
Photograph of the cardiac surface after ablation. The electrode insertion points are marked by black dots. C:
Action potential amplitude map before shock application. Black corresponds to zero action potential
amplitude, white to maximal action potential amplitude. D: Action potential amplitude map after shock
application. E: Activation map before shock application. Colors code the time after stimulus application at
which a surface element is activated. Black areas are activated first, white areas last (see scale). Small red
“x”marks the stimulation site, arrow indicate the direction of propagation. F: Activation map after shock
application. Activation is blocked at the site of shock application (small red dots indicate shock electrode
positions.
doi:10.1371/journal.pone.0144833.g003
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thresholds stated above never succeeded in creating a lesion (n = 7). All these data are from sin-
gle ablations; they are complemented by the data for longer lesions below (a blocking lesion
implies that all individual ablations are blocking).
Effect of shock amplitude on geometry of ablated volume
When we varied the shock amplitude while keeping all other shock parameters fixed (4 mm
electrodes spacing, 20 pulses at 1 Hz) and subsequently stained the tissue with PI, we found a
characteristic dependency of the geometry of the ablated volume on shock amplitude, shown
in Fig 4. For a small shock amplitude (1 kV/cm), we observe ablation only in limited areas
around the ablation electrodes (see Fig 5A). For a larger shock amplitude (2 kV/cm), the areas
around the electrodes merge so that a contiguous lesion is created (see Fig 5B).
Computed field distributions for both 1 and 2 kV/cm are shown in Fig 5C and 5D. They
support the idea that tissue dies whenever the local field strength is above a critical threshold.
Comparing Fig 5A and 5C and Fig 5B and 5D, we estimate that this critical threshold should
be in the range of 3–5 kV/cm.
Longer lesions with multiple nsPEF applications
We created longer lesions by placing single nsPEF ablations along a line, just like lesions are
created using RF ablation. For electrode spacing 2.3 mm, our lesions consisted of 4–5 single
ablations. The subsequent electrode positions were shifted ~ 0.7 more by ~3 mm, so that the
gap was ~0.7 mm and the lesion length was ~15 mm. For electrode spacing 4 mm, we used 3–4
single ablations and electrode positions were shifted by 4.7 mm, leading to lesion lengths of
Fig 4. Success Rate of nsPEF ablation for different field strengths. The threshold field strength (T) was
2.3 kV for 2.3 mm electrode separation and 4 kV for 4 mm electrode separation. The bars show combined
results for both field strengths, relative to the thresholds.
doi:10.1371/journal.pone.0144833.g004
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~16 mm. Based on our experience with single application, we chose set our standard protocol
to 6 pulses at 3 Hz. The field strength was set to 2.3 kV for 2.3 mm electrode separation and to
4.3 kV for 4 mm electrode separation (i.e. ~10 kV/cm if calculated simply as "voltage over dis-
tance"). A representative example with 2.3 mm electrode separation is shown in Fig 6.
Panel B shows that electrical activity has ceased where nsPEF was applied. Panel C shows
that activation propagates around the treated region (as indicated by the arrows), and the
smooth change in activation time indicates that this propagation happens with approximately
constant speed. While activation also propagates from the stimulation site towards the lesion,
Fig 5. Ablated volume varies with shock amplitude. Black dots indicate the positions of the ablation
electrodes, surface fluorescence of propidium iodide (red) shows which part of the tissue has been ablated.
Ablation electrodes are 4 mm apart. A: Shock amplitude 1 kV,B: Shock amplitude 2 kV. C: Computed field
distribution (|E|) for a 1 kV shock. D: Computed field distribution for a 2 kV shock.
doi:10.1371/journal.pone.0144833.g005
Fig 6. Evaluation of nsPEF lesion (compare Fig 3 for details). A: Photograph of the cardiac surface after ablation. The pairs of black dots mark the
locations of the (successive) positions of the ablation electrodes, the black diagonal line in the upper right is the stimulation electrode.B: Action potential
amplitude map after ablation.C: Activation map after ablation.
doi:10.1371/journal.pone.0144833.g006
Ablation with Nanosecond Pulsed Electric Fields
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the abrupt jump in activation time at the lesion is strong evidence that conduction block has
indeed been achieved.
Lesion statistics
We created a total of 16 lesions in 12 rabbit hearts. Based on our single ablations, we expected
consistent ablation success with low individual ablation times (< 2 s), and indeed, all lesions
created were nonconducting (16/16). For 2.3 mm electrode separation, we assessed the lesion
width both with PI stains and TTC stains (see Fig 7). For PI stains (n = 7) we found an average
width of 2.3+/-0.2 mm, while with TTC stains (n = 7), the average was 3.1+/-0.56 mm. For 4
mm electrode separation (n = 2), the evaluation of the lesion with TTC staining gave a thick-
ness between 5 and 6 mm.
3D Geometry of lesions
We also investigated the 3D geometry of selected lesions we created. Fig 8 shows TTC staining
in a series of sections from epi- to endocardium (Panel A) and a 3D reconstruction of the lesion
geometry (Panel B). The section geometry is far more consistent from epi- to endocardium
than is typical for RF or cryoablation [10]. Also, the boundary of the ablated region is very
sharp; the zoomed picture (Panel C) shows that even at the level of individual cardiac fibers
there is a very abrupt transition from unstained to almost fully stained tissue.
Fig 7. Lesion width statistics. For shocks of 2.3 kV over 2.3 mm, we evaluated lesion width in some hearts
with TTC staining and in other hearts with PI staining. For shock of 4 kV over 4 mm, we evaluated lesion width
in all hearts with TTC staining. Bar heights show averages, error bars indicate standard deviations.
doi:10.1371/journal.pone.0144833.g007
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Ablation Speed
We were able to create non-conducting lesion with 6 pulses delivered at 3 Hz in every attempt.
This corresponds to a treatment time of 1.67 s per location. We also tried to achieve ablation
with single pulses, but even at field strengths of 5–6 kV, the maximum that our generator could
supply, we were not able to create lesions consistently.
Thermal effects
The amount energy deposited per pulse can be computed from the shock parameters and the
generator capacitance (3.1 nF), and it is less than 8 mJ (for 2.3 kV, a typical pulse amplitude).
Even with 20 pulses the total energy is below 200 mJ (compared to typically ~1,000 J per site
for RF ablation). In direct experimental measurements at the midpoint between the electrodes,
Fig 8. 3D reconstruction of the geometry of the ablated volume. A: A stack of TTC-stained sections of
the lesion. White and red areas identify dead and live tissues, respectively. Sections are 300 μm thick. B:
Three-dimensional rendering of the lesion geometry, obtained from the sections in Panel A. The red bars
indicate the successive positions of the ablation electrodes. C: Zoom into one of the TTC-stained sections at
the boundary of the ablated volume.
doi:10.1371/journal.pone.0144833.g008
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we were not able to detect any temperature increase after the shock, indicating that the increase
was smaller than ~0.1°C.
Discussion
We have demonstrated that using nsPEFs, we can reliably ablate myocardial tissue with more
consistent lesion cross section than RF/cryoablation, in a fraction of the time, and without ther-
mal side effects. Lesion width was consistent and could be adjusted between 2 and 5.5 mm by
choosing different electrode distances and pulse amplitudes.
Implications for recurrence
Atrial fibrillation usually recurs when pulmonary vein (PV) isolation lesions become conduc-
tive again [9]. While the precise mechanism for the loss of lesion integrity is not known, it is
reasonable to assume that lesions most easily become conductive at locations at which they are
particularly narrow (or even have a gap). It appears that a promising approach to prolong
lesion integrity is to make lesions more uniform in width, specifically avoiding that the width is
below some minimum width anywhere along the lesion. Our data suggest that nsPEF ablation
may give electrophysiologists the tools to achieve such greater lesion uniformity.
Absence of thermal effects
The complete absence of thermal effects and the associated complications side effects is a
major advantage of nsPEF ablation over RF and cryoablation. RF ablation suffers from signifi-
cant rates of major complications [12,13]. Esophageal injuries are common [29] and can in
extreme, rare [30] cases lead to fistulae, which are associated with high mortality [31]. PV ste-
nosis is another important complication that was reported to occur in 0 to 19% (mean, 2%;
median, 3.1%) after 2004 [32]. It is possible that the nsPEF rates for PV stenosis will be lower
(PV stenosis is a consequence of the inflammatory response [33,34], which may be aggravated
by heating). Compared to cryoablation, the elimination of phrenic nerve palsy [35] would be a
major improvement. For stroke, another important complication of thermal ablation, it is less
clear how often it is a direct consequence of thermal effects, but a since nsPEF ablation excludes
the risks of charring and thrombus formation, it should provide some benefit here as well.
Speed of applications
Since nsPEF ablation requires only requires less than 2 seconds per ablation site, it is realistic to
assume that overall procedure times, e.g. for AF ablation, can be reduced substantially. Such a
reduction will reduce the overall surgical risk, reduce the stress on patients, and free up
resources of the hospitals that are expected to perform more and more ablation procedures.
Effect of shock amplitude on lesion geometry
Our experimental finding that smaller shock amplitudes lead to ablation only in the vicinity of
the electrodes, while larger shock amplitudes ablate the whole region between the electrode is
consistent with similar experiments performed in 3D in-vitro tumor models [36] as well as
computations of field distributions [37]. For 3D in-vitro tumor models, a critical field that pre-
dicted cell death was also identified [36].
While we get good qualitative agreement between our experiments and model, we recognize
that our model excludes important electrical properties of the myocardium, in particular its
anisotropic conductivity and the fact that the direction of highest conductivity changes across
Ablation with Nanosecond Pulsed Electric Fields
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the myocardial wall (”twisted anisotropy”). We are in the process of developing a model that
includes these features of cardiac tissue.
Comparison to DC and pulsed electric fields of longer duration
There is a long history of DC ablation, in fact DC used to be the standard modality of thermal
ablation before it was established that RF has lower complication rates [38,39]. Also, pulsed
electric fields have been used before for ablation of cardiac tissue [40–42], although these stud-
ies used longer pulses (in the micro- and millisecond range) and much higher ablation energies.
Ablation with millisecond pulses has been attempted by placing circular electrodes on pig
ventricular myocardium and applying defibrillator shocks of 100-200J [41]. While lesion
depths up to 7 mm were achieved, the lesions were not uniformly transmural. Microsecond
pulses were successfully used to create nonconducting lesions in pig atrial appendages,
although with energies approximately 1,000 times higher than those presented here [40].
The fact that we demonstrate nsPEF ablation here with a fraction of the applied energy sug-
gests that nsPEF ablation is more efficient for ablation than longer pulses. This result is consis-
tent with theoretical analyses that suggest that nsPEF ablation electroporates cells in a tissue
more uniformly. It has been shown in modeling studies that the strong fields used for nanosec-
ond pulses electroporate all cells indiscriminately, while the weaker fields associated with lon-
ger pulses lead to spatially heterogeneous, incomplete electroporation [26,43]. Recent
experiments in rat embryonic cardiomyocytes likewise suggest that nsPEF electroporates cells
more uniformly that millisecond pulsed electric fields [44]. While it would be in principle pos-
sible to generate pulses that are both strong and long, such pulses would deposit large energies,
which would lead to unwanted thermal effects. Nanosecond pulses also have the benefit that it
has already been shown that besides ablating cells via necrosis, they can also ablate them via
apoptosis [45,46].
Clinical application of nsPEFs ablation
In this paper, we are demonstrating the principle of nsPEF ablation in isolated hearts. In clini-
cal practice, nsPEF ablation could either be performed via surgical clamps during open heart
surgery, or using a catheter (just as RF- or cryoablation). For nsPEF ablation during open heart
surgery, surgical clamps similar to those used in RF ablation [47] could be equipped with arrays
of penetrating electrodes to allow the creation of extended lesions with a single nsPEF applica-
tion. The development of this technology is straightforward and we plan to move it towards
clinical practice first. For nsPEF catheter ablation, retractable penetrating electrodes would be
placed in a catheter similar to those used in RF ablation. The thin, sharpened electrodes can be
inserted into the myocardium with small contact force. Note that the wall thickness of the rab-
bit ventricles (2–4 mm) closely matches that of the human atria, which would be one important
target for nsPEF ablation. Ventricular ablation, while performed less commonly, is also a very
important target due to the grave risk of ventricular tachyarrhythmias that patients receiving
ventricular typically carry. The substantially thicker human ventricles would not pose a special
challenge to our nsPEF ablation approach; the electrode length would be increased accordingly.
It is reasonable to expect that the consistent cross section of lesions that we observe, and that is
due to the translational symmetry of our electrode configuration across the wall, would also be
observed in thicker tissue (because the translational symmetry would still be given).
Arrhythmia induction
An important concern regarding shock application in a clinical setting is that shocks may
induce fibrillation in the patient. In our rabbit model, nsPEFs never induced fibrillation that
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lasted long enough for us to observe it (several seconds would be detectable for us), but it is
well-known that larger species such as human, dog, and pig are more prone to the induction of
fibrillation [48]. In fact, application of microsecond shocks to pig heart frequently does induce
fibrillation. This problem can, however, be addressed by timing the shock application so that it
occurs right after the QRS complex (i.e. when all of the myocardium is depolarized) [49].
Limitations
This study has several limitations. Even though the consistent width of our lesions suggests
that recurrence will be low, this has not been tested experimentally. Long-term survival studies
that are necessary to address this limitation, and we are currently planning such studies. Also,
it would be desirable to have an electrode configuration in which the electrodes don't penetrate
the tissue multiple times. We are currently testing an alternative electrode configuration in
which one electrode is places on the epicardium and the other electrode on the endocardium.
This new configuration is straightforward to implement for open heart surgery, but for a cathe-
ter-based approach, there will be challenges related to the alignment of catheters.
Conclusions
Ablation with nsPEF is a promising alternative to RF and cryoablation that may overcome lim-
itations of current clinical practice. Chronic animal studies and studies in large animal hearts
are needed to evaluate the clinical potential of nsPEF ablation.
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